Skip to main content
. 2015 Mar 6;2015(3):CD003443. doi: 10.1002/14651858.CD003443.pub3

Comparison 29. PERPHENAZINE vs TRIFLUOPERAZINE.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Leaving the study early: 1. Any reason 1   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.1 short term 1 105 Risk Ratio (M‐H, Random, 95% CI) 0.63 [0.38, 1.03]
2 Leaving the study early: 2. Due to adverse events 1   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
2.1 short term 1 105 Risk Ratio (M‐H, Random, 95% CI) 0.65 [0.11, 3.76]
3 Adverse events: Movement disorders 1   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
3.1 akathisia ‐ short term 1 105 Risk Ratio (M‐H, Random, 95% CI) 2.29 [0.63, 8.38]
3.2 akinesia ‐ short term 1 105 Risk Ratio (M‐H, Random, 95% CI) 0.33 [0.01, 7.85]
3.3 dyskinesia ‐ short term 1 105 Risk Ratio (M‐H, Random, 95% CI) 0.98 [0.14, 6.71]
3.4 parkinsonism ‐ short term 1 105 Risk Ratio (M‐H, Random, 95% CI) 2.62 [0.73, 9.32]